These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 15952999)

  • 1. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.
    Mitchell CD; Richards SM; Kinsey SE; Lilleyman J; Vora A; Eden TO;
    Br J Haematol; 2005 Jun; 129(6):734-45. PubMed ID: 15952999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol.
    Igarashi S; Manabe A; Ohara A; Kumagai M; Saito T; Okimoto Y; Kamijo T; Isoyama K; Kajiwara M; Sotomatsu M; Sugita K; Sugita K; Maeda M; Yabe H; Kinoshita A; Kaneko T; Hayashi Y; Ikuta K; Hanada R; Tsuchida M
    J Clin Oncol; 2005 Sep; 23(27):6489-98. PubMed ID: 16170158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which steroids should we choose for the treatment of adult acute lymphoblastic leukemia?
    Zheng C; Liu X; Wu J; Cai X; Zhu W; Sun Z
    Am J Hematol; 2010 Oct; 85(10):817-8. PubMed ID: 20815080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
    Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous 6-mercaptopurine decreases salvage after relapse in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group study CCG 1922.
    Tolar J; Bostrom BC; La MK; Sather HN
    Pediatr Blood Cancer; 2005 Jul; 45(1):5-9. PubMed ID: 15481062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers.
    McNeer JL; Nachman JB
    Br J Haematol; 2010 Jun; 149(5):638-52. PubMed ID: 20408842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired adrenal function after glucocorticoid therapy in children with acute lymphoblastic leukemia.
    Petersen KB; Müller J; Rasmussen M; Schmiegelow K
    Med Pediatr Oncol; 2003 Aug; 41(2):110-4. PubMed ID: 12825213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
    Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low incidence of CNS relapse with cranial radiotherapy and intrathecal methotrexate in acute lymphoblastic leukemia.
    Raje NS; Vaidya SJ; Kapoor G; Pai SK; Nair CN; Kurkure PA; Magrath IT; Advani SH
    Indian Pediatr; 1996 Jul; 33(7):556-60. PubMed ID: 8979564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to glucocorticoids in childhood acute lymphoblastic leukemia: impact of relationship between ex vivo sensitivity and in vivo concentration on risk factor analysis.
    Styczynski J; Koltan A; Wysocki M
    Neoplasma; 2006; 53(2):168-73. PubMed ID: 16575474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of cortivazol in childhood acute lymphoblastic leukemia.
    Styczynski J; Kurylak A; Wysocki M
    Anticancer Res; 2005; 25(3B):2253-8. PubMed ID: 16158972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia.
    Pession A; Valsecchi MG; Masera G; Kamps WA; Magyarosy E; Rizzari C; van Wering ER; Lo Nigro L; van der Does A; Locatelli F; Basso G; Aricò M
    J Clin Oncol; 2005 Oct; 23(28):7161-7. PubMed ID: 16192600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukaemia.
    Elmantaser M; Stewart G; Young D; Duncan R; Gibson B; Ahmed SF
    Arch Dis Child; 2010 Oct; 95(10):805-9. PubMed ID: 20576660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circumvention of glucocorticoid resistance in childhood leukemia.
    Haarman EG; Kaspers GJ; Pieters R; Rottier MM; Veerman AJ
    Leuk Res; 2008 Sep; 32(9):1417-23. PubMed ID: 18395253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia.
    Wallace AM; Tucker P; Williams DM; Hughes IA; Ahmed SF
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):770-6. PubMed ID: 12780755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of corticosteroid-induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low-dose adrenocorticotropin test.
    Rix M; Birkebaek NH; Rosthøj S; Clausen N
    J Pediatr; 2005 Nov; 147(5):645-50. PubMed ID: 16291357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial.
    Fifoot AA; Ting JY
    Emerg Med Australas; 2007 Feb; 19(1):51-8. PubMed ID: 17305661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is there a risk of steroid-induced adrenal deficit after induction treatment of acute lymphoblastic leukemia?].
    Bélien-Pallet V; Cabrol S; Fasola S; Petit A; Landman-Parker J; Auvrignon A; Leverger G
    Arch Pediatr; 2010 Dec; 17(12):1637-44. PubMed ID: 20943354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.